This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Triaminic Long Acting Cough
- Starting date:
- January 31, 2013
- Posting date:
- March 19, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-23797
Recalled Products
A. Triaminic Long Acting Cough
Reason
The child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed when the tamper-evident seal is still in place.
Depth of distribution
Wholesalers and pharmacies across Canada.
Affected products
A. Triaminic Long Acting Cough
DIN, NPN, DIN-HIM
DIN 02277972Dosage form
Syrup
Strength
Dextromethorphan Hydrobromide 7.5 mg/5 mL
Lot or serial number
All lots with expiry dates up to June 2013
Companies
- Recalling Firm
-
Novartis Consumer Health Canada Inc.
Suite 205, West Tower 2233 Argentia Road
Mississauga
L5N 2X7
Ontario
CANADA
- Marketing Authorization Holder
-
Novartis Consumer Health Canada Inc.
Suite 205, West Tower 2233 Argentia Road
Mississauga
L5N 2X7
Ontario
CANADA